miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Pathologic features of idiopathic pulmonary fibrosis (IPF) include genetic predisposition, activation of the unfolded protein response, telomere attrition, and cellular senescence. The mechanisms leading to alveolar epithelial cell (AEC) senescence are poorly understood. MicroRNAs (miRNAs) have been reported as regulators of cellular senescence. Senescence markers including p16, p21, p53, and senescence-associated β-galactosidase (SA-βgal) activity were measured in type II AECs from IPF lungs and unused donor lungs. miRNAs were quantified in type II AECs using gene expression arrays and quantitative RT-PCR. Molecular markers of senescence (p16, p21, and p53) were elevated in IPF type II AECs. SA-βgal activity was detected in a greater percentage in type II AECs isolated from IPF patients (23.1%) compared to patients with other interstitial lung diseases (1.2%) or normal controls (0.8%). The relative levels of senescence-associated miRNAs miR-34a, miR-34b, and miR-34c, but not miR-20a, miR-29c, or miR-let-7f were significantly higher in type II AECs from IPF patients. Overexpression of miR-34a, miR-34b, or miR-34c in lung epithelial cells was associated with higher SA-βgal activity (27.8%, 35.1%, and 38.2%, respectively) relative to control treated cells (8.8%). Targets of miR-34 miRNAs, including E2F1, c-Myc, and cyclin E2, were lower in IPF type II AECs. These results show that markers of senescence are uniquely elevated in IPF type II AECs and suggest that the miR-34 family of miRNAs regulate senescence in IPF type II AECs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“cellular senescence has been linked to the pathogenesis of chronic lung diseases such as chronic obstructive pulmonary disease [14, 15] or IPF [16–20].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to lung fibroblasts, evidence has emerged that alveolar epithelial cells can become senescent in IPF [16, 20, 24].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“[27] No background subtraction was performed, and the median feature pixel intensity was used as the raw signal before normalization.”
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“[11] Importantly, a subpopulation of type II AECs in IPF lungs stained for SA-βgal (blue cells, Fig 1A and 1B and S1 Fig).”
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Cellular senescence, a condition of stable cell-cycle arrest, is involved in multiple physiologic processes including embryonic development, [42] tumor suppression, [43] tissue repair, [44, 45] and organismal aging.”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“Because telomere shortening can lead to senescence [31], these findings suggest senescence may occur in the type II AECs in miR-34 Mediated Senescence in Idiopathic Pulmonary Fibrosis”
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci‐Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38098 · Cited by 3,409
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 1×
“Cellular senescence, a condition of stable cell-cycle arrest, is involved in multiple physiologic processes including embryonic development, [42] tumor suppression, [43] tissue repair, [44, 45] and organismal aging.”
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 1×
“[8] Molecular changes that regulate cellular senescence include the p53-p21-pRb or the p16-pRb pathways.”
Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668 · cited 2×
“[24] Importantly, SA-βgal activity was detected in an average of 23.”
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Recent reports have associated mutations in TERT or TERC [4, 29, 30] and the presence of short telomeres in type II AECs [4] to the development of IPF.”
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342 · cited 1×
“[17, 39] Activation of p53 induces p21 leading to induction of cell-cycle arrest by inhibiting cyclin E and CDK2 expression.”
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“The prevalence of idiopathic pulmonary fibrosis (IPF) is estimated to be 14 to 43 per 100,000 people in the United States [1] and increases with age ranging from 4 per 100,000 people aged 18 to 34 years to 227 per 100,000 people among those aged 75 years or older.”
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186
Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process
Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002213 · Cited by 1,129
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,079
Jun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 1×
“Cellular senescence, a condition of stable cell-cycle arrest, is involved in multiple physiologic processes including embryonic development, [42] tumor suppression, [43] tissue repair, [44, 45] and organismal aging.”
Tazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707351104 · Cited by 903 · cited 2×
“[34] Activation of miR-34 miRNAs results in multiple phenotypic changes depending on the target it modulates.”
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 1×
“Recent reports have associated mutations in TERT or TERC [4, 29, 30] and the presence of short telomeres in type II AECs [4] to the development of IPF.”
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Self-citationRegulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 1×
“[51] In the present study, we report that p16, p21, and p53 are elevated in IPF lungs.”
MicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821 · cited 1×
“Whether their expression in IPF type II AECs contributes to lung fibrosis in addition to senescence, similar to their purported role in age-related cardiac fibrosis, [53] will require additional study.”
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · cited 4×
“766 2.025 2.224 2.439 14.514 2.024 miR-197 miR-210 miR-886 miR-939 miR-1183 miR-1229 miR-1268 0.426 0.406 0.399 0.472 0.451 0.481 0.446 Higher in miR-449b miR-449c miR-551b 2.870 6.006 5.413 3.900 4.480 IPF = idiopathic pulmonary fibrosis; AECs = alveolar epithelial cells”
InfluentialRaghu, G., Chen, S.-Y., Yeh, W.-S., Maroni, B., Li, Q., Lee, Y.-C., & Collard, H. R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70101-8 · Cited by 716 · cited 1×
“[2] Although IPF is now recognized to be a disease associated with chronological aging, age-associated molecular changes contributing to the development or progression of IPF are incompletely understood.”
Self-citationTelomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573 · cited 1×
“[4, 47] DNA damage signaling leads to activation of ataxia telangiectasia Fig 4.”
Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506306102 · Cited by 532 · cited 2×
“[25] It was found that cells overexpressing miR-34a, miR-34b, or miR-34c had a relative increase in the numbers of cells expressing SA-βgal activity (Fig 5 and S5 Fig).”
Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M., Handley, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1698oc · Cited by 506 · cited 1×
“[13] Reports of differential expression of miRNAs in the lungs of IPF patients [14] suggest they may be involved in the pathogenesis of IPF.”
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408 · cited 1×
“[46] Two senescence pathways have been proposed, the p53-p21-pRb pathway and the p16-pRb pathway.”
Critical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385
The p53/miR-34 axis in development and disease
Rokavec, M., Li, H., Jiang, L., & Hermeking, H. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju003 · Cited by 354 · cited 1×
“[17, 18] In this study, we measured senescence markers, p16, p21, p53, and SA-βgal activity, in lung tissues and purified type II alveolar epithelial cells (AECs) from IPF patients and control subjects.”
Kuwano, K., Kunitake, R., Kawasaki, M., Nomoto, Y., Hagimoto, N., Nakanishi, Y., & Hara, N. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.154.2.8756825 · Cited by 339 · cited 1×
“[7, 40, 41] However, the type of senescent cells and mediators of senescence in IPF have not been fully characterized.”
Insufficient autophagy in idiopathic pulmonary fibrosis
Araya, J., Kojima, J., Takasaka, N., Ito, S., Fujii, S., Hara, H., Yanagisawa, H., Kobayashi, K., Tsurushige, C., Kawaishi, M., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00213.2012 · Cited by 325 · cited 2×
“[7, 40, 41] However, the type of senescent cells and mediators of senescence in IPF have not been fully characterized.”
Minagawa, S., Araya, J., Numata, T., Nojiri, S., Hara, H., Yumino, Y., Kawaishi, M., Odaka, M., Morikawa, T., Nishimura, S. L., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2010 · Cited by 323 · cited 1×
“[7, 40, 41] However, the type of senescent cells and mediators of senescence in IPF have not been fully characterized.”
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Self-citationFabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M. S., Rossi, S., Barbarotto, E., Cimmino, A., Adair, B., Wojcik, S. E., et al. (2011) · JAMA · doi:10.1001/jama.2010.1919 · Cited by 293
Replicative senescence: a critical review
Cristofalo, V. J., Lorenzini, A., Allen, R. G., Torres, C., & Tresini, M. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.010 · Cited by 274 · cited 4×
“[9, 10] In this study, miRNA oligonucleotide arrays identified 22 miRNAs whose expression was elevated in type II AECs isolated from IPF lungs.”
InfluentialmiR-34/449 miRNAs are required for motile ciliogenesis by repressing CP110
Song, R., Walentek, P., Sponer, N., Klimke, A., Lee, J. S., Dixon, G., Harland, R., Wan, Y., Lishko, P., Lize, M., et al. (2014) · Nature · doi:10.1038/nature13413 · Cited by 228 · cited 1×
“[52] Here we demonstrated the up-regulation of miR-34 family members and elevation of senescence markers in purified type II AECs isolated from IPF patients.”
Kumamoto, K., Spillare, E. A., Fujita, K., Horikawa, I., Yamashita, T., Appella, E., Nagashima, M., Takenoshita, S., Yokota, J., & Harris, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2780 · Cited by 223 · cited 1×
“Of these miRNAs, we confirmed the miR-34 family of miRNAs as SAmiRNAs [17, 32, 34] whose expression is up-regulated in type II AECs.”
Computational identification of microRNAs and their targets
Zhang, B., Pan, X., Wang, Q., Cobb, G. P., & Anderson, T. A. (2006) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2006.08.006 · Cited by 195 · cited 1×
“[13] Reports of differential expression of miRNAs in the lungs of IPF patients [14] suggest they may be involved in the pathogenesis of IPF.”
Kropski, J. A., Pritchett, J. M., Zoz, D. F., Crossno, P. F., Markin, C., Garnett, E. T., Degryse, A. L., Mitchell, D. B., Polosukhin, V. V., Rickman, O. B., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1162oc · Cited by 178 · cited 1×
“[4, 5] Shortened peripheral blood telomeres have also been shown to predict worse outcome of IPF patients.”
Hanak, V., Golbin, J. M., Hartman, T. E., & Ryu, J. H. (2008) · Chest · doi:10.1378/chest.07-3005 · Cited by 177
Marmai, C., Sutherland, R. E., Kim, K. K., Dolganov, G. M., Fang, X., Kim, S. S., Jiang, S., Golden, J. A., Hoopes, C. W., Matthay, M. A., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00212.2010 · Cited by 172 · cited 2×
“[22] The membranes were washed with 50 mM Tris-HCl containing 0.”
Self-citationLafferty‐Whyte, K., Cairney, C. J., Jamieson, N. B., Oien, K. A., & Keith, W. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.003 · Cited by 124 · cited 2×
“A number of senescence-associated miRNAs (SA-miRNAs) have been reported [15, 16] including the miR-34 family of miRNAs that are downstream effectors of p53-mediated cellular senescence.”
MicroRNAs as Mediators of the Ageing Process
Harries, L. (2014) · Genes · doi:10.3390/genes5030656 · Cited by 101
Pines, J. (1994) · Nature · doi:10.1038/369520a0 · Cited by 80
The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence
Poliseno, L., Pitto, L., Simili, M., Mariani, L., Riccardi, L., Ciucci, A., Rizzo, M., Evangelista, M., Mercatanti, A., Pandolfi, P. P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002542 · Cited by 78
Noppe, G., Dekker, P., de Koning‐Treurniet, C., Blom, J., van Heemst, D., Dirks, R. W., Tanke, H. J., Westendorp, R. G. J., & Maier, A. B. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20796 · Cited by 77 · cited 1×
“[9, 11, 12] MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression at the posttranscriptional level.”
Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
Cannell, I. G., & Bushell, M. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12182 · Cited by 74
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
Ick, S., Ryerson, C. J., Lee, J. S., Kukreja, J., Barry, S. S., Jones, K. D., Elicker, B. M., Kim, D. S., Papa, F. R., Collard, H. R., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-105 · Cited by 44 · cited 1×
“[23] Briefly, the sections were incubated in PBS containing 5% normal goat serum and 1% bovine serum albumin (BSA), then incubated with a 1:100 dilution of mouse anti-human p16 (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-human p21 (Santa Cruz Biotechnology) or mouse anti-human p53 antibody (Santa Cruz Biot…”
Self-citationThe p53/miR-34 axis in development and disease
Matjaz, Rokavec, Huihui, Li, Longchang, Jiang, Heiko, & Hermeking (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 3
Cited by
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
IPF lung fibroblasts have a senescent phenotype
Álvarez, D., Cárdenes, N., Sellarés, J., Bueno, M., Corey, C., Hanumanthu, V. S., Peng, Y., D’Cunha, H., Sembrat, J., Nouraie, M., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2017 · Cited by 342
“TGF- (23) and senescence-associated miRNAs (14).”
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267
Self-citationPan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E. J., Citrin, D. E., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.216 · Cited by 242
Metadata
- Authors
- Disayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., Erle, D. J., Collard, H. R., & Wolters, P. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Wolters, Paul J.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-06-30
- Volume
- 11
- Issue
- 6
- Pages
- e0158367
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4928999
- OpenAlex
- W2463253169
- Cited by
- 136
- References
- 54
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 13 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 18 · 2019: 12 · 2018: 17 · 2017: 22 · 2016: 2
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Nina Ireland Program in Lung Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- idiopathic pulmonary fibrosis, cellular senescence, alveolar type II cells, miR-34 family, microRNA, senescence-associated β-galactosidase, p16, p21, p53, E2F1, c-Myc, cyclin E2, unfolded protein response, telomere shortening
- MeSH terms
- A549 Cells, Gene Expression Regulation, Humans, Lung, Biomarkers, Case-Control Studies, Cellular Senescence, Disease Progression, Gene Expression Profiling, MicroRNAs, Microarray Analysis, Idiopathic Pulmonary Fibrosis, Alveolar Epithelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.